SS
ZVSA

SBI Securities’s ZyVersa Therapeutics ZVSA Stock Holding History

SBI Securities’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-151
Closed -$102 – 4330
2025
Q2 		$102 Buy
151
+101
+202% +$66 ﹤0.01% 3533
2025
Q1 		$31 Hold
50
– – ﹤0.01% 3765
2024
Q4 		$53 Buy
+50
New +$79 ﹤0.01% 3631

Other funds holding ZVSA

GA
Guerra Advisors Miami, Florida $271M AUM 27.78% 1-Year Est. Return

SBI Securities's ZVSA Position: Q3 2025 in Review

SBI Securities sold out of ZyVersa Therapeutics (ZVSA) in Q3 2025, closing a stake of 151 shares — an estimated $102 sold.

SBI Securities first reported a position in ZVSA in Q4 2024 and held it in 3 quarters. The position peaked at $102 in Q2 2025. 1 fund tracked by Wall St. Rank holds ZVSA as of Q3 2025.

  • SBI Securities reported no remaining ZyVersa Therapeutics position as of Q3 2025 after selling out during the quarter.
  • SBI Securities sold 151 ZyVersa Therapeutics shares in Q3 2025, an estimated $102.
  • SBI Securities first reported a position in ZyVersa Therapeutics in Q4 2024 and held it in 3 quarters.
  • SBI Securities's ZyVersa Therapeutics position peaked at $102 in Q2 2025.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.